Pre-Conference Workshop Day
November 14, 2023
8.30am – 10.30am Workshop A
Exploring the Capabilities of Rod Mediated Dark Adaptation for Dry AMD
Synopsis
Being able to arrest the progression of dry AMD presents a key area to improve patient outcomes. Currently, identifying and halting the progression of dry AMD remains a substantial challenge. Join this workshop to:
- Understand how well rod mediated dark adaption can detect intermediate dry AMD
- Assess the ability of this approach to arrest early AMD or stabilize intermediate AMD
- Clarify the impact of drusen deposits on rod dysfunction
- Modify test parameters to reduce test length by incorporating AI
- Ensure the FDA understand how the results from a rod mediated dark adaption test mean for a patients every day life
11.00AM – 1.00PM Workshop B
Exploring Recent Developments in Functional Endpoints for Dry AMD
Synopsis
Solidifying accurate, reliable and reproducible functional end points remains a vitally important topic to propel the dry AMD therapeutic development forward. Attend this session to:
- Assess how to determine functional differences
- Ensure end point sensitivity to detect minimal lesion growth
- Demonstrate a clear clinical significance
- Explore how to optimize the measuring of reading speed
- Assess how to increase the sensitivity of microperimetry
- Strategize how to increase the use of functional end points in comparison to structural end points
1:00 pm Lunch Refreshments
2PM – 4PM Workshop C
Comparing a Multitude of Delivery Methods for Dry AMD
Synopsis
There a several delivery methods available for dry AMD therapeutics, each with their own advantages and challenges. Learn from the experts to:
- Exploring if the intravitreal treatment burden may preclude real world sustained adoption
- Discovering the capabilities of slow-release formulations
- Evaluate a Systemic Approach for dry AMD Therapeutic Delivery
- Assessing if systemic treatments may better target the disease process
- Examine the Intricacies of the Suprachoroidal Delivery Approach
- Optimizing the parameters for suprachoroidal delivery with microneedles such as microneedle length, pressure, and particle size